<p>In each leave-one-out cross-validation fold for a given disease, a different gene is retained from the set of known disease genes (red, blue, orange). The remaining genes known to be associated with that particular disease are mapped onto the network and used as prior knowledge (training set) to compute gene-disease scores for all the genes in the network. A test set, including the left-out gene and a set of candidates previously sampled from a pool of genes (the genes in a network or the intersection of the sets of genes in different networks), is sorted according to the obtained gene-disease scores. The performance is then determined by assessing the position of the left-out gene in the ranked test set. We average the overall and per d...
A major challenge in bio-medicine is finding the genetic causes of human diseases, and researchers a...
<p>42 microarray datasets were used, each studying a phenotype that has a corresponding KEGG or Meta...
In-silico identification of potential target genes for disease is an essential aspect of drug target...
<p>Results of each tested prioritization method on the NCBI PPI network. Mean and standard deviation...
<p>Leave-one-out cross-validation results of HDiffusion on the PPI, HEFalMp cutoff = 0.2, STRING sou...
<p>Results of each tested prioritization method on the STRINGv8.2 network. Mean and standard deviati...
<p>(A) The integrated network is constructed from String and HumanNet; (B) The integrated network is...
<p>The full dataset is a gene expression matrix with 8,000 features (the genes) as rows and 30 sampl...
Background: Identifying disease gene from a list of candidate genes is an important task in bioinfor...
<p>Gene expression data with two class labels are normalized by the z-scoring approach. For class la...
Abstract Background Genome-wide disease-gene finding approaches may sometimes provide us with a long...
The compilation of protein-protein interaction (PPI) data and the application of network traversal a...
Objective: In the context of "network medicine", gene prioritization methods represent one of the ma...
Finding genes associated with human genetic disorders is one of the most challenging problems in bio...
In-silico identification of potential target genes for disease is an essential aspect of drug target...
A major challenge in bio-medicine is finding the genetic causes of human diseases, and researchers a...
<p>42 microarray datasets were used, each studying a phenotype that has a corresponding KEGG or Meta...
In-silico identification of potential target genes for disease is an essential aspect of drug target...
<p>Results of each tested prioritization method on the NCBI PPI network. Mean and standard deviation...
<p>Leave-one-out cross-validation results of HDiffusion on the PPI, HEFalMp cutoff = 0.2, STRING sou...
<p>Results of each tested prioritization method on the STRINGv8.2 network. Mean and standard deviati...
<p>(A) The integrated network is constructed from String and HumanNet; (B) The integrated network is...
<p>The full dataset is a gene expression matrix with 8,000 features (the genes) as rows and 30 sampl...
Background: Identifying disease gene from a list of candidate genes is an important task in bioinfor...
<p>Gene expression data with two class labels are normalized by the z-scoring approach. For class la...
Abstract Background Genome-wide disease-gene finding approaches may sometimes provide us with a long...
The compilation of protein-protein interaction (PPI) data and the application of network traversal a...
Objective: In the context of "network medicine", gene prioritization methods represent one of the ma...
Finding genes associated with human genetic disorders is one of the most challenging problems in bio...
In-silico identification of potential target genes for disease is an essential aspect of drug target...
A major challenge in bio-medicine is finding the genetic causes of human diseases, and researchers a...
<p>42 microarray datasets were used, each studying a phenotype that has a corresponding KEGG or Meta...
In-silico identification of potential target genes for disease is an essential aspect of drug target...